Our Conferences and Workshops

Embracing research, collaboration and change: Conference 2023

We are delighted to announce the Children with Cancer UK Conference 2023 will be taking place on 19-20 September 2023.

For Childhood Cancer Awareness Month, we’re re-launching our research conference, focusing on Embracing Research, Collaboration and Change.

The conference will bring together leading researchers, clinicians, healthcare professionals, early career researchers, representatives from funders across the childhood cancer sector and patient advocates to share their latest findings and discuss the latest trends in the field. You’ll learn about cutting-edge research, clinical trials, and innovative treatment strategies that are improving outcomes for children and young adults with cancer.

Childhood Cancer 2019 conference

We are delighted to announce that our annual Childhood Cancer 2019 conference will be hosted by Newcastle University on 9-10^th September 2019. The programme will include keynote lectures, disease specific updates, proffered talks and poster presentations covering the full range of childhood & TYA cancers. Clinicians, researchers, oncology nurses, clinician scientists and students will find great value in attending and participating in this event. Details of how to register and submit abstracts will be available in early April 2019.

New Osteosarcoma research partnership

Osteosarcoma is a long way behind other cancers in terms of new treatments and improvement in survival due to a lack of research investment.

However, the International Osteosarcoma Research Symposium 2019, hosted by Children with Cancer UK and the Bone Cancer Research Trust, brought together researchers from across the globe to identify research progress, challenges that need to be overcome and opportunities to move research forward.

This year Children with Cancer UK will be committing £500,000 to osteosarcoma research. The Bone Cancer Research Trust launched a £450,000, UK-wide observational clinical trial for all ages.

Read the Executive Summary for the International Osteosarcoma Research Symposium that took place on 31 January 2019.

International Scientific and Medical Conference 2018

12th-14th September, Westminster

A Holistic Approach to Precision Medicine, a landmark conference examining the way we understand cancer

This conference explored the way forward within the full US NIH definition of Precision Medicine.

Venue – Church House Conference Centre, Westminster

Childhood Cancer 2017, 18-19 September 2017, Newcastle, UK

Childhood and TYA Cancer 2017 was a two-day medical, scientific and educational meeting exploring the latest state-of-the-art translational science being (and to be) used in the diagnosis and treatment of cancer in children and young people.

We had platform presentations by leading-edge clinicians and researchers and we welcomed the submission of poster presentations from researchers working in these areas of translational and precision medicine.

The Royal College of Paediatrics and Child Health approved CPD points for this conference.

Childhood Cancer 2016

5th to 7th September 2016 at Church House Conference Centre, London
We were joined by an outstanding line-up of speakers from the UK, Europe and the US to examine three themes over the three days of the conference:

Is precision medicine a reality for children with cancer in 2016?
Can we harness the power of the immune system to cure childhood cancer?
What do we know about influenceable causes of childhood cancer?

The format of the meeting was designed to facilitate the sharing of information and knowledge, providing a forum for the discussion of important issues, networking and the development of new collaborations.

In total, around 150 delegates and speakers participated in the meeting over the three days and we achieved our aim of bringing together a broad range of scientists and clinicians from different areas of childhood cancer research and care.

Drug delivery in paediatric brain tumours (workshop)

This workshop, chaired by Professor David Walker, was developed to highlight the priority of drug delivery research and clinical trials as part of initiatives to improve outcomes for children with brain tumours.

We wanted to identify areas of pre-clinical and clinical research that can be pursued now, with a view to early translation into clinical trials, to identify drug delivery strategies holding promise for future deployment and to identify optimal development pathways for their translation to clinical trials.

With colleagues joining us from the US, Canada and Europe to share their expertise and experience, we enjoyed two days of lively discussion.